Side-by-side comparison of AI visibility scores, market position, and capabilities
Dublin world's largest industrial gas company (NYSE: LIN) at $33B 2024 sales; 25.9% ROC, 29.5% op margin, $9.4B operating cash flow, semiconductor electronics gases + clean hydrogen competing with Air Liquide.
Linde plc is a Dublin, Ireland-incorporated global industrial gas and engineering company — publicly traded on the New York Stock Exchange (NYSE: LIN) as an S&P 500 Materials component and the world's largest industrial gas company by revenue and market capitalization — producing, distributing, and marketing atmospheric gases (oxygen, nitrogen, argon), process gases (hydrogen, helium, carbon dioxide, acetylene), and specialty gases for semiconductor manufacturing, healthcare, food and beverage, steel production, chemical processing, and energy applications through approximately 65,000 employees in 100 countries. In fiscal year 2024, Linde reported $33 billion in revenue, 25.9% return on capital (ROC), 29.5% operating margin, 10% EPS growth, $9.4 billion in operating cash flow, and returned $7.1 billion to shareholders through dividends and share repurchases — demonstrating industry-leading profitability metrics that reflect Linde's combination of long-term supply contracts, pricing power in specialty applications, and operational efficiency. Linde was formed from the $90 billion merger of Linde AG (Germany) and Praxair (US) completed in 2018, creating a combined industrial gas leader that nearly matches the scale of the other two major global industrial gas companies (Air Liquide and Air Products) combined. CEO Sanjiv Lamba leads Linde's strategy of expanding clean hydrogen production for energy transition, electronics gases supply for semiconductor manufacturing capacity additions, and healthcare oxygen delivery in emerging markets.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.